Oppenheimer & Co’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Oppenheimer & Co’s Portfolio IBDS Stock Details IBDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$653K	Sell	27,086 -4,954	-15%	-$120K	0.01%	1101
2026 Q2	$776K	Sell	32,040 -6,254	-16%	-$151K	0.01%	1054
2026 Q1	$928K	Buy	38,294 +1,862	+5%	+$45.2K	0.01%	900
2025 Q4	$885K	Buy	36,432 +1,958	+6%	+$47.6K	0.01%	852
2025 Q3	$839K	Buy	34,474 +714	+2%	+$17.3K	0.01%	976
2025 Q2	$819K	Sell	33,760 -121	-0.4%	-$2.92K	0.01%	948
2025 Q1	$819K	Buy	33,881 +2,411	+8%	+$58K	0.01%	886
2024 Q4	$754K	Buy	31,470 +2,994	+11%	+$72.1K	0.01%	912
2024 Q3	$694K	Buy	+28,476	New	+$686K	0.01%	914

Other funds holding IBDS

Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return

Howland Capital Management Boston, Massachusetts $2.86B AUM 15.15% 1-Year Est. Return

Gratus Wealth Advisors Virginia Beach, Virginia $783M AUM 14.73% 1-Year Est. Return

Sigma Investment Counselors Northville, Michigan $2.14B AUM 11.72% 1-Year Est. Return

RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

TABR Capital Management Orange, California $136M AUM 24.56% 1-Year Est. Return

Klingman & Associates New York $2.41B AUM 15.13% 1-Year Est. Return

MV Capital Management Bethesda, Maryland $1.1B AUM 18.81% 1-Year Est. Return

Glenview Trust Louisville, Kentucky $7.42B AUM 21.14% 1-Year Est. Return

Oppenheimer & Co's IBDS Position: Q3 2026 in Review

Oppenheimer & Co reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 15% in Q3 2026, selling an estimated $120K and leaving 27,086 shares worth $653K. The position accounts for 0.01% of the portfolio, ranked #1101.

Oppenheimer & Co first reported a position in IBDS in Q3 2024 and has held it in 9 quarters since. The position peaked at $928K in Q1 2026. 213 funds tracked by Wall St. Rank hold IBDS as of Q3 2026.

Oppenheimer & Co held 27,086 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $653K as of Q3 2026.
Oppenheimer & Co sold 4,954 iShares iBonds Dec 2027 Term Corporate ETF shares in Q3 2026, an estimated $120K.
iShares iBonds Dec 2027 Term Corporate ETF made up 0.01% of Oppenheimer & Co's portfolio in Q3 2026, its #1101 holding.
Oppenheimer & Co first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2024 and has held it in 9 quarters since.
Oppenheimer & Co's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $928K in Q1 2026.
213 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q3 2026.

Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.